Accepted at 1:43 a.m. Oct, 15, 2024 by andrewmathias8
Author: andrewmathias8
Related Note: 1474580882205
Rationale for change

see "adverse effects"
Source: AMBOSS - https://next.amboss.com/us/article/GN0Bcg?utm_source=navbar&utm_medium=anki&utm_campaign=anki&utm_term=%25CE%25B22%2Bagonists&guid=l%253Eg%257B%2521Nw4b%253F&aid=298bfc66-b119-4c76-b7ef-8bfc7d192ab2&uid=ptfeLeLy0#Z350eb8cd29b2f98aee1fae10a72648e9

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::02_Allergy_&_Pulmonary::02_Asthma_Therapy #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::05_Treatment_of_COPD_and_Asthma #AK_Step2_v12::#SketchyNeurology::04_Movement_&_Neurodegenerative_Disorders::03_Movement_Disorders::02_Tremor:_Postural-Action_&_Resting_Tremors #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::05_Asthma_drugs #AK_Step1_v12::#OME::PreClinical::General_Physiology::Smooth_Muscle #AK_Other::Only_Step_1 #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::04_Albuterol_vs_Salmeterol #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::05_Treatment_of_COPD_and_Asthma::Extra #AK_Step1_v12::#NBME::24 #PANCE::EOR::PEDS #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Pulmonology::05_Obstructive_Lung_Disease::03_Asthma_Treatments #AK_Step1_v12::^Systems::Respiratory::Pharmacology #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::06_Beta_Blockers_(MOA,_Indications,_AR,_CI) #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::15_beta-blockers::02_Selectivity::*B_Agonists::B2_Agonists::Long_Acting #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::06_Asthma_Treatment #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::05_Asthma_drugs::01_Inhaled_beta_2_-agonists::*Long_Acting_B2_Agonists